Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19186223 | METHODS FOR MAKING L-GLUFOSINATE | April 2025 | August 2025 | Allow | 4 | 1 | 0 | No | No |
| 19184659 | LIPID-ENCAPSULATED DUAL-CLEAVING ENDONUCLEASE FOR DNA AND GENE EDITING | April 2025 | September 2025 | Allow | 5 | 1 | 0 | No | No |
| 18770533 | MICROORGANISMS AND METHODS FOR THE CONTINUOUS PRODUCTION OF FATTY ACIDS, FATTY ALCOHOLS, AND CULTURED PROTEIN FROM C1 SUBSTRATES | July 2024 | June 2025 | Abandon | 11 | 1 | 1 | No | No |
| 18741103 | USE AND PRODUCTION OF STORAGE-STABLE NEUTRAL METALLOPROTEASE | June 2024 | March 2026 | Abandon | 21 | 0 | 1 | No | No |
| 18676494 | BETA-GLYCOSIDASE SS-BGL MUTANT FOR MODIFYING GINSENOSIDE AND APPLICATION THEREOF | May 2024 | October 2025 | Allow | 16 | 2 | 0 | No | No |
| 18661739 | METHOD FOR PRODUCING SCLAREOL BY FERMENTATION OF CIGAR TOBACCO FLOWER BUDS | May 2024 | October 2024 | Allow | 5 | 1 | 0 | No | No |
| 18660840 | RECOMBINANT OLIVETOLIC ACID CYCLASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS | May 2024 | January 2026 | Allow | 21 | 1 | 0 | No | No |
| 18658735 | COMPOSITIONS AND METHODS FOR TREATMENT OF HOMOCYSTINURIA | May 2024 | February 2026 | Allow | 22 | 1 | 0 | No | No |
| 18657713 | ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | May 2024 | February 2026 | Allow | 21 | 2 | 0 | Yes | No |
| 18641275 | COMPOSITIONS AND METHODS OF DUST CONTROL | April 2024 | February 2026 | Abandon | 22 | 1 | 0 | No | No |
| 18635214 | SERINE PROTEASES | April 2024 | May 2025 | Allow | 13 | 0 | 0 | No | No |
| 18627748 | METHOD FOR EXTRACTING PULLULAN POLYSACCHARIDE FROM HIGH-VISCOSITY FERMENTATION BROTH | April 2024 | August 2024 | Allow | 5 | 1 | 0 | No | No |
| 18623612 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | April 2024 | April 2025 | Allow | 13 | 0 | 1 | Yes | No |
| 18614099 | KETOREDUCTASE POLYPEPTIDES FOR THE PRODUCTION OF (R)-3-HYDROXYTHIOLANE | March 2024 | April 2025 | Allow | 12 | 1 | 0 | Yes | No |
| 18611182 | DNA SEQUENCE MODIFICATION-BASED GENE DRIVE | March 2024 | November 2025 | Allow | 20 | 1 | 0 | No | No |
| 18437445 | GLUCOAMYLASE ENGINEERED YEAST AND FERMENTATION METHODS | February 2024 | April 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18435340 | METHODS FOR MAKING L-GLUFOSINATE | February 2024 | March 2025 | Allow | 14 | 1 | 0 | No | No |
| 18435544 | METHODS FOR MAKING L-GLUFOSINATE | February 2024 | April 2025 | Allow | 14 | 1 | 0 | No | No |
| 18416852 | THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME | January 2024 | September 2025 | Abandon | 20 | 1 | 1 | No | No |
| 18412090 | INSECT INHIBITORY TOXIN FAMILY ACTIVE AGAINST HEMIPTERAN AND/OR LEPIDOPTERAN INSECTS | January 2024 | March 2025 | Abandon | 14 | 1 | 1 | No | No |
| 18402680 | ENGINEERED NUCLEIC ACID-GUIDED NUCLEASES | January 2024 | July 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18525234 | UDP-DEPENDENT GLYCOSYLTRANSFERASE FOR HIGH EFFICIENCY PRODUCTION OF REBAUDIOSIDES | November 2023 | April 2025 | Allow | 16 | 1 | 0 | No | No |
| 18512848 | Enzyme Variants and Polynucleotides Encoding the Same | November 2023 | August 2025 | Allow | 21 | 2 | 1 | No | No |
| 18511394 | METHODS OF PRODUCING MORPHINAN ALKALOIDS AND DERIVATIVES | November 2023 | June 2025 | Allow | 19 | 1 | 0 | No | No |
| 18506648 | Liquid Cleaning Compositions Comprising Protease Variants | November 2023 | December 2024 | Allow | 14 | 1 | 0 | No | No |
| 18504743 | Liquid Cleaning Compositions Comprising Protease Variants | November 2023 | December 2024 | Allow | 13 | 2 | 0 | Yes | No |
| 18496269 | AUTOMATIC DISHWASHING DETERGENT COMPOSITIONS | October 2023 | February 2025 | Abandon | 16 | 0 | 1 | No | No |
| 18384044 | PRODUCTION OF CAROTENOIDS AND APOCAROTENOIDS | October 2023 | April 2025 | Allow | 17 | 2 | 1 | Yes | No |
| 18485895 | TUNABLE NANOSCALE CAGES FROM SELF-ASSEMBLING DNA AND PROTEIN BUILDING BLOCKS | October 2023 | March 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18485501 | Construction Method and Application of Microorganism Capable of Realizing High Production of Lacto-N-tetrose | October 2023 | April 2024 | Allow | 6 | 1 | 0 | No | No |
| 18484214 | METHODS OF REDUCING ODOR | October 2023 | August 2025 | Allow | 22 | 3 | 0 | Yes | No |
| 18453987 | METHODS AND ORGANISMS WITH INCREASED CARBON FLUX EFFICIENCIES | August 2023 | June 2025 | Allow | 22 | 2 | 1 | No | No |
| 18264639 | PROTEIN HAVING 1,3-FUCOSYLTRANSFERASE ACTIVITY, AND METHOD FOR PRODUCING FUCOSE-CONTAINING SUGAR | August 2023 | January 2026 | Allow | 30 | 1 | 0 | Yes | No |
| 18275163 | PREPHENATE DEHYDRATASE VARIANT AND METHOD OF PRODUCING BRANCHED-CHAIN AMINO ACIDS USING THE SAME | July 2023 | February 2026 | Allow | 31 | 1 | 0 | No | No |
| 18227147 | HETEROLOGOUS PRODUCTION OF 10-METHYLSTEARIC ACID | July 2023 | December 2024 | Abandon | 16 | 1 | 0 | No | No |
| 18352899 | KETOREDUCTASE POLYPEPTIDES AND POLYNUCLEOTIDES | July 2023 | November 2024 | Allow | 16 | 1 | 1 | No | No |
| 18260333 | BACILLUS SUBTILIS GENETICALLY ENGINEERED BACTERIUM FOR PRODUCING TAGATOSE AND METHOD FOR PREPARING TAGATOSE | July 2023 | January 2026 | Allow | 30 | 1 | 0 | Yes | No |
| 18270750 | METHOD FOR PRODUCING CELLOOLIGOSACCHARIDE | July 2023 | January 2026 | Allow | 31 | 1 | 0 | No | No |
| 18269907 | Xylanase Variants | June 2023 | January 2026 | Allow | 30 | 1 | 0 | No | No |
| 18339027 | MICROORGANISMS AND METHODS FOR THE CONTINUOUS CO-PRODUCTION OF HIGH-VALUE, SPECIALIZED PROTEINS AND CHEMICAL PRODUCTS FROM C1-SUBSTRATES | June 2023 | October 2024 | Allow | 16 | 2 | 1 | Yes | No |
| 18258770 | A DFL-PRODUCING STRAIN | June 2023 | March 2026 | Abandon | 32 | 0 | 1 | No | No |
| 18338242 | RECOMBINANT OLIVETOLIC ACID CYCLASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS | June 2023 | April 2024 | Allow | 10 | 1 | 0 | Yes | No |
| 18267625 | METHOD FOR PRODUCING ALCOHOLS USING A SUPPORT ON WHICH MICROORGANISMS ARE IMMOBILISED | June 2023 | January 2026 | Allow | 31 | 1 | 0 | No | No |
| 18267531 | MODIFIED POLYPEPTIDE HAVING XYLANASE ACTIVITY | June 2023 | February 2026 | Allow | 32 | 2 | 0 | Yes | No |
| 18267524 | MODIFIED POLYPEPTIDE HAVING XYLANASE ACTIVITY | June 2023 | February 2026 | Allow | 32 | 2 | 0 | Yes | No |
| 18267326 | CYTOCHROME P450 ENZYME MUTANT AND APPLICATION THEREOF | June 2023 | November 2025 | Allow | 29 | 0 | 1 | Yes | No |
| 18333776 | COMPOSITIONS FOR SACCHARIFICATION OF CELLULOSIC MATERIAL | June 2023 | September 2024 | Allow | 15 | 1 | 0 | No | No |
| 18208030 | PRODUCTION OF ISOPRENOIDS | June 2023 | July 2024 | Allow | 13 | 1 | 0 | No | No |
| 18266238 | OLIVETOLIC ACID CYCLASE VARIANTS AND METHODS FOR THEIR USE | June 2023 | March 2026 | Abandon | 33 | 0 | 1 | No | No |
| 18327373 | A UNIVERSAL PLATFORM TO ENHANCE CRISPR-BASED GENE EDITING FOR IN VIVO THERAPIES | June 2023 | April 2024 | Allow | 11 | 0 | 1 | No | No |
| 18199278 | METHODS FOR GENOMIC INTEGRATION FOR KLUYVEROMYCES HOST CELLS | May 2023 | August 2024 | Allow | 15 | 1 | 0 | No | No |
| 18197870 | COMPOSITIONS AND METHODS INVOLVING ENGINEERED P27 | May 2023 | January 2025 | Allow | 20 | 2 | 1 | Yes | No |
| 18304187 | Inducible, Tunable, and Multiplex Human Gene Regulation Using CRISPR-Cpf1 | April 2023 | September 2024 | Allow | 17 | 2 | 0 | No | No |
| 18249751 | MICROORGANISMS FOR DITERPENE PRODUCTION | April 2023 | February 2026 | Allow | 34 | 1 | 1 | Yes | No |
| 18301460 | PROTEASE VARIANTS AND USES THEREOF | April 2023 | July 2024 | Allow | 15 | 1 | 0 | Yes | No |
| 18030970 | POLY-3-HYDROXYALKANOATES HAVING VINYL MOIETIES AND METHOD OF PRODUCING SUCH | April 2023 | January 2026 | Abandon | 33 | 0 | 1 | No | No |
| 18182136 | CONSTRUCTION OF A LACTOBACILLUS CASEI ETHANOLOGEN | March 2023 | January 2026 | Abandon | 34 | 1 | 0 | No | No |
| 18179136 | METHODS FOR MAKING L-GLUFOSINATE | March 2023 | October 2023 | Allow | 7 | 1 | 0 | No | No |
| 18024614 | METHOD TO PRODUCE A SYNTHESIS PRODUCT, E.G. METHANE UTILIZING METHANOGENIC MICROORGANISMS IN A MICROBIAL ELECTROLYSIS CELL (MEC) BY APPLYING A SEPARATED NUTRIENT FEEDING STRATEGY | March 2023 | November 2025 | Allow | 33 | 1 | 0 | No | No |
| 18021627 | 2709 ALKALI PROTEASE MUTANT MODIFIED BASED ON MOLECULAR DYNAMICS CALCULATION AND USE THEREOF | February 2023 | December 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 18170454 | OVER-EXPRESSION OF GDS1 IN YEAST FOR INCREASED ETHANOL AND DECREASED ACETATE PRODUCTION | February 2023 | December 2025 | Allow | 34 | 1 | 1 | No | No |
| 18040629 | PRODUCTION OF A MIXTURE OF NEUTRAL NON-FUCOSYLATED OLIGOSACCHARIDES BY A CELL | February 2023 | February 2024 | Allow | 13 | 1 | 1 | Yes | No |
| 18161236 | BIOSYNTHESIS OF RETINOIDS | January 2023 | November 2024 | Allow | 22 | 1 | 1 | No | No |
| 18018304 | PROCESSES FOR IMPROVING PERFORMANCE AND ENERGY EFFICIENCY IN BIOMASS CONVERSION TO SUGARS, BIOCHEMICALS, BIOFUELS, AND/OR BIOMATERIALS | January 2023 | October 2025 | Allow | 33 | 1 | 0 | Yes | No |
| 17790417 | D-xylulose 4-epimerase, mutants and uses thereof | January 2023 | November 2025 | Allow | 41 | 1 | 1 | Yes | No |
| 18015329 | METHOD FOR INCREASING THE EXTRACTION RATE OF CHONDROITIN SULFATE PREPARED FROM TILAPIA SKULL | January 2023 | January 2026 | Allow | 37 | 2 | 1 | No | No |
| 18013427 | OPTIMIZED IBE FERMENTATION METHOD FOR UPGRADING ACETONE | December 2022 | January 2026 | Allow | 36 | 2 | 0 | No | No |
| 18001741 | SEMISYNTHETIC PROCESS FOR THE PREPARATION OF COLCHICINE | December 2022 | July 2025 | Allow | 31 | 1 | 1 | Yes | No |
| 18062628 | BIOSYNTHETIC PRODUCTION OF GAMMA-LACTONES | December 2022 | April 2025 | Allow | 28 | 1 | 1 | Yes | No |
| 18062198 | Integration Sites in CHO Cells | December 2022 | February 2024 | Allow | 14 | 0 | 0 | No | No |
| 17999017 | COMPOSITIONS AND METHODS FOR PRODUCING HUMAN MILK OLIGOSACCHARIDES | November 2022 | October 2025 | Allow | 35 | 1 | 1 | Yes | No |
| 18055713 | LIPID-ENCAPSULATED DUAL-CLEAVING ENDONUCLEASE FOR DNA AND GENE EDITING | November 2022 | August 2023 | Allow | 9 | 1 | 0 | Yes | No |
| 17998759 | CONVERTING LIGNOCELLULOSIC FEEDSTOCK TO FUEL | November 2022 | December 2025 | Allow | 37 | 2 | 1 | No | No |
| 17986618 | LACTASE ENZYMES WITH IMPROVED PROPERTIES | November 2022 | October 2024 | Allow | 23 | 1 | 1 | No | No |
| 17924944 | ENGINEERED MICROORGANISM FOR IMPROVED PENTOSE FERMENTATION | November 2022 | January 2026 | Abandon | 38 | 1 | 1 | No | No |
| 17983665 | PROBIOTIC BACTERIA FOR YEAST BIOETHANOL PRODUCTION | November 2022 | June 2024 | Allow | 19 | 1 | 0 | Yes | No |
| 18052066 | Biocementation Method and System | November 2022 | August 2024 | Allow | 21 | 1 | 0 | Yes | No |
| 18050245 | VARIANT AIM | October 2022 | August 2024 | Abandon | 22 | 1 | 0 | Yes | No |
| 17969715 | AFFINITY TAG FOR RECOMBINATION PROTEIN RECRUITMENT | October 2022 | August 2024 | Abandon | 22 | 0 | 1 | No | No |
| 17918533 | GLUCOAMYLASE AND METHODS OF USE THEREOF | October 2022 | August 2025 | Allow | 34 | 1 | 1 | Yes | No |
| 17995957 | ARRANGEMENT AND METHOD FOR TREATMENT OF LIGNOCELLULOSIC BIOMASS | October 2022 | December 2025 | Abandon | 38 | 1 | 1 | No | No |
| 17917932 | A METHOD FOR PROCESSING RAW PLANT MATERIAL, ESPECIALLY LEGUMES INTO PTOTEIN HAVING A NUTRITIONAL AND FEED VALUE, BIOETHANOL, BIOGAS AND FERTILISER MATERIALS | October 2022 | March 2026 | Abandon | 41 | 1 | 0 | No | No |
| 17917859 | PROCESS FOR THE DIRECT ENZYMATIC CONVERSION OF AMINO SUGARS; ENZYME AND COMPOSITIONS FOR USE IN THE PROCESS | October 2022 | November 2025 | Allow | 37 | 2 | 0 | No | No |
| 17912242 | BIOMANUFACTURING SYSTEMS AND METHODS FOR PRODUCING ORGANIC PRODUCTS FROM RECOMBINANT MICROORGANISMS | October 2022 | September 2025 | Abandon | 36 | 2 | 1 | No | No |
| 17957218 | AprL-CLADE PROTEASE VARIANTS AND USES THEREOF | September 2022 | February 2025 | Allow | 29 | 1 | 0 | Yes | No |
| 17913858 | GLUCOSE PRODUCTION METHOD AND ETHANOL PRODUCTION METHOD | September 2022 | October 2025 | Allow | 37 | 2 | 0 | Yes | No |
| 17934560 | PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY | September 2022 | May 2024 | Allow | 19 | 1 | 0 | No | No |
| 17900590 | ENZYMES AND APPLICATIONS THEREOF | August 2022 | April 2024 | Allow | 19 | 1 | 0 | No | No |
| 17799414 | PREPARING AND MODIFYING MEROTERPENE POLYKETIDES, KETONES, AND LACTONES FOR CANNABINOID SEMISYNTHESIS | August 2022 | June 2025 | Abandon | 34 | 0 | 1 | No | No |
| 17635157 | NOVEL FRUCTOSE-4-EPIMERASE AND METHOD FOR PREPARING TAGATOSE USING SAME | August 2022 | July 2025 | Allow | 41 | 2 | 0 | No | No |
| 17798197 | PROCESS FOR PRODUCING ETHANOL FROM RAW STARCH USING ALPHA-AMYLASE VARIANTS | August 2022 | October 2025 | Abandon | 38 | 2 | 1 | No | No |
| 17882680 | IMMOBILIZED ENZYME PRODUCTION LINE, METHOD OF MAKING AN IMMOBILIZED ENZYME PRODUCTION LINE, AND METHOD OF MAKING COMPOUNDS USING THE IMMOBILIZED ENZYME PRODUCTION LINE | August 2022 | August 2024 | Abandon | 24 | 1 | 1 | No | No |
| 17797351 | ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME | August 2022 | October 2025 | Allow | 39 | 2 | 1 | Yes | No |
| 17816892 | METHODS OF REDUCING ODOR | August 2022 | July 2023 | Allow | 11 | 2 | 1 | Yes | No |
| 17816630 | HETEROLOGOUS BIOSYNTHESIS OF NODULISPORIC ACID | August 2022 | April 2024 | Allow | 20 | 0 | 1 | Yes | No |
| 17759537 | Polypeptide Variants | July 2022 | March 2025 | Allow | 32 | 0 | 1 | Yes | No |
| 17814417 | VARIANT G6P G7P GLUCOAMYLASE COMPOSITIONS AND METHODS | July 2022 | November 2025 | Abandon | 39 | 1 | 1 | No | No |
| 17871400 | METHOD FOR PRODUCING MERCAPTANS BY DISULFIDE ENZYME HYDROGENOLYSIS | July 2022 | July 2024 | Abandon | 23 | 1 | 0 | No | No |
| 17759272 | ENZYME COMPOSITIONS AND USES THEREOF | July 2022 | December 2025 | Abandon | 40 | 2 | 1 | No | No |
| 17813950 | KETOREDUCTASE POLYPEPTIDES FOR THE PRODUCTION OF (R)-3-HYDROXYTHIOLANE | July 2022 | December 2023 | Allow | 17 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner RAGHU, GANAPATHIRAM.
With a 26.7% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 15.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner RAGHU, GANAPATHIRAM works in Art Unit 1652 and has examined 1,407 patent applications in our dataset. With an allowance rate of 70.5%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 27 months.
Examiner RAGHU, GANAPATHIRAM's allowance rate of 70.5% places them in the 33% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by RAGHU, GANAPATHIRAM receive 1.70 office actions before reaching final disposition. This places the examiner in the 35% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by RAGHU, GANAPATHIRAM is 27 months. This places the examiner in the 71% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +29.1% benefit to allowance rate for applications examined by RAGHU, GANAPATHIRAM. This interview benefit is in the 77% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 30.6% of applications are subsequently allowed. This success rate is in the 61% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 58.7% of cases where such amendments are filed. This entry rate is in the 84% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 71.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 59% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 63% percentile among all examiners. Of these withdrawals, 77.8% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 71.0% are granted (fully or in part). This grant rate is in the 78% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 10.2% of allowed cases (in the 94% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.